nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Clonidine—glaucoma	0.0613	0.228	CbGbCtD
Vardenafil—PDE6G—optic choroid—glaucoma	0.0523	0.452	CbGeAlD
Vardenafil—CYP3A4—Pilocarpine—glaucoma	0.049	0.182	CbGbCtD
Vardenafil—CYP3A4—Brinzolamide—glaucoma	0.0384	0.143	CbGbCtD
Vardenafil—CYP3A4—Dorzolamide—glaucoma	0.0371	0.138	CbGbCtD
Vardenafil—CYP3A4—Methazolamide—glaucoma	0.0331	0.123	CbGbCtD
Vardenafil—CYP3A4—Acetazolamide—glaucoma	0.0264	0.0982	CbGbCtD
Vardenafil—CYP3A4—Clonidine—glaucoma	0.0239	0.0888	CbGbCtD
Vardenafil—PDE6H—eye—glaucoma	0.0109	0.0944	CbGeAlD
Vardenafil—PDE6H—retina—glaucoma	0.0108	0.0936	CbGeAlD
Vardenafil—PDE6G—eye—glaucoma	0.0105	0.0909	CbGeAlD
Vardenafil—PDE6G—retina—glaucoma	0.0104	0.0901	CbGeAlD
Vardenafil—PDE5A—endothelium—glaucoma	0.00847	0.0732	CbGeAlD
Vardenafil—PDE5A—eye—glaucoma	0.00416	0.0359	CbGeAlD
Vardenafil—PDE5A—retina—glaucoma	0.00412	0.0356	CbGeAlD
Vardenafil—PDE5A—connective tissue—glaucoma	0.00401	0.0346	CbGeAlD
Vardenafil—Pain—Brimonidine—glaucoma	0.000372	0.000658	CcSEcCtD
Vardenafil—Dyspnoea—Dorzolamide—glaucoma	0.000371	0.000655	CcSEcCtD
Vardenafil—Visual impairment—Betaxolol—glaucoma	0.000371	0.000655	CcSEcCtD
Vardenafil—Insomnia—Brinzolamide—glaucoma	0.00037	0.000654	CcSEcCtD
Vardenafil—Somnolence—Dorzolamide—glaucoma	0.00037	0.000653	CcSEcCtD
Vardenafil—Muscle spasms—Clonidine—glaucoma	0.00037	0.000653	CcSEcCtD
Vardenafil—Dyspnoea—Travoprost—glaucoma	0.000369	0.000652	CcSEcCtD
Vardenafil—Hypotension—Pilocarpine—glaucoma	0.000367	0.000649	CcSEcCtD
Vardenafil—Paraesthesia—Brinzolamide—glaucoma	0.000367	0.000649	CcSEcCtD
Vardenafil—Dyspepsia—Dorzolamide—glaucoma	0.000366	0.000647	CcSEcCtD
Vardenafil—Dyspnoea—Brinzolamide—glaucoma	0.000364	0.000644	CcSEcCtD
Vardenafil—Dyspepsia—Travoprost—glaucoma	0.000364	0.000644	CcSEcCtD
Vardenafil—Asthenia—Apraclonidine—glaucoma	0.000364	0.000643	CcSEcCtD
Vardenafil—Somnolence—Brinzolamide—glaucoma	0.000363	0.000642	CcSEcCtD
Vardenafil—Vision blurred—Clonidine—glaucoma	0.000362	0.00064	CcSEcCtD
Vardenafil—Dyspepsia—Brinzolamide—glaucoma	0.00036	0.000636	CcSEcCtD
Vardenafil—Eye disorder—Betaxolol—glaucoma	0.000359	0.000635	CcSEcCtD
Vardenafil—Pruritus—Apraclonidine—glaucoma	0.000359	0.000634	CcSEcCtD
Vardenafil—Tinnitus—Betaxolol—glaucoma	0.000358	0.000634	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000358	0.000633	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Travoprost—glaucoma	0.000357	0.000632	CcSEcCtD
Vardenafil—Cardiac disorder—Betaxolol—glaucoma	0.000357	0.000631	CcSEcCtD
Vardenafil—Flushing—Betaxolol—glaucoma	0.000357	0.000631	CcSEcCtD
Vardenafil—Ill-defined disorder—Clonidine—glaucoma	0.000357	0.000631	CcSEcCtD
Vardenafil—Pain—Dorzolamide—glaucoma	0.000356	0.000629	CcSEcCtD
Vardenafil—Insomnia—Pilocarpine—glaucoma	0.000355	0.000628	CcSEcCtD
Vardenafil—Pain—Travoprost—glaucoma	0.000354	0.000626	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000353	0.000624	CcSEcCtD
Vardenafil—Paraesthesia—Pilocarpine—glaucoma	0.000353	0.000624	CcSEcCtD
Vardenafil—Asthenia—Bimatoprost—glaucoma	0.000353	0.000624	CcSEcCtD
Vardenafil—Angioedema—Clonidine—glaucoma	0.000351	0.000621	CcSEcCtD
Vardenafil—Dyspnoea—Pilocarpine—glaucoma	0.00035	0.000619	CcSEcCtD
Vardenafil—Pain—Brinzolamide—glaucoma	0.00035	0.000618	CcSEcCtD
Vardenafil—Somnolence—Pilocarpine—glaucoma	0.000349	0.000617	CcSEcCtD
Vardenafil—Angiopathy—Betaxolol—glaucoma	0.000349	0.000617	CcSEcCtD
Vardenafil—Pruritus—Bimatoprost—glaucoma	0.000348	0.000615	CcSEcCtD
Vardenafil—Immune system disorder—Betaxolol—glaucoma	0.000347	0.000614	CcSEcCtD
Vardenafil—Diarrhoea—Apraclonidine—glaucoma	0.000347	0.000613	CcSEcCtD
Vardenafil—Malaise—Clonidine—glaucoma	0.000347	0.000613	CcSEcCtD
Vardenafil—Mediastinal disorder—Betaxolol—glaucoma	0.000347	0.000613	CcSEcCtD
Vardenafil—Dyspepsia—Pilocarpine—glaucoma	0.000346	0.000611	CcSEcCtD
Vardenafil—Syncope—Clonidine—glaucoma	0.000345	0.000609	CcSEcCtD
Vardenafil—Feeling abnormal—Dorzolamide—glaucoma	0.000343	0.000606	CcSEcCtD
Vardenafil—Feeling abnormal—Travoprost—glaucoma	0.000341	0.000603	CcSEcCtD
Vardenafil—Conjunctivitis—Timolol—glaucoma	0.00034	0.000601	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dorzolamide—glaucoma	0.00034	0.000601	CcSEcCtD
Vardenafil—Palpitations—Clonidine—glaucoma	0.00034	0.000601	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000339	0.0006	CcSEcCtD
Vardenafil—Gastrointestinal pain—Travoprost—glaucoma	0.000339	0.000598	CcSEcCtD
Vardenafil—Loss of consciousness—Clonidine—glaucoma	0.000338	0.000597	CcSEcCtD
Vardenafil—Feeling abnormal—Brinzolamide—glaucoma	0.000337	0.000595	CcSEcCtD
Vardenafil—Mental disorder—Betaxolol—glaucoma	0.000337	0.000595	CcSEcCtD
Vardenafil—Pain—Pilocarpine—glaucoma	0.000336	0.000594	CcSEcCtD
Vardenafil—Sweating—Timolol—glaucoma	0.000335	0.000593	CcSEcCtD
Vardenafil—Dizziness—Apraclonidine—glaucoma	0.000335	0.000593	CcSEcCtD
Vardenafil—Erythema—Betaxolol—glaucoma	0.000335	0.000592	CcSEcCtD
Vardenafil—Epistaxis—Timolol—glaucoma	0.00033	0.000583	CcSEcCtD
Vardenafil—Abdominal pain—Dorzolamide—glaucoma	0.000329	0.000581	CcSEcCtD
Vardenafil—Sinusitis—Timolol—glaucoma	0.000328	0.00058	CcSEcCtD
Vardenafil—Chest pain—Clonidine—glaucoma	0.000327	0.000579	CcSEcCtD
Vardenafil—Arthralgia—Clonidine—glaucoma	0.000327	0.000579	CcSEcCtD
Vardenafil—Abdominal pain—Travoprost—glaucoma	0.000327	0.000579	CcSEcCtD
Vardenafil—Anxiety—Clonidine—glaucoma	0.000326	0.000577	CcSEcCtD
Vardenafil—Asthenia—Acetazolamide—glaucoma	0.000325	0.000575	CcSEcCtD
Vardenafil—Dizziness—Bimatoprost—glaucoma	0.000325	0.000575	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000325	0.000575	CcSEcCtD
Vardenafil—Feeling abnormal—Pilocarpine—glaucoma	0.000324	0.000572	CcSEcCtD
Vardenafil—Discomfort—Clonidine—glaucoma	0.000323	0.000572	CcSEcCtD
Vardenafil—Vomiting—Apraclonidine—glaucoma	0.000322	0.00057	CcSEcCtD
Vardenafil—Muscle spasms—Betaxolol—glaucoma	0.000322	0.000569	CcSEcCtD
Vardenafil—Gastrointestinal pain—Pilocarpine—glaucoma	0.000321	0.000568	CcSEcCtD
Vardenafil—Hypersensitivity—Brimonidine—glaucoma	0.000321	0.000567	CcSEcCtD
Vardenafil—Dry mouth—Clonidine—glaucoma	0.00032	0.000566	CcSEcCtD
Vardenafil—Dermatitis—Apraclonidine—glaucoma	0.000319	0.000565	CcSEcCtD
Vardenafil—Headache—Apraclonidine—glaucoma	0.000318	0.000562	CcSEcCtD
Vardenafil—Vision blurred—Betaxolol—glaucoma	0.000315	0.000558	CcSEcCtD
Vardenafil—Rhinitis—Timolol—glaucoma	0.000315	0.000557	CcSEcCtD
Vardenafil—Asthenia—Brimonidine—glaucoma	0.000312	0.000552	CcSEcCtD
Vardenafil—Infection—Clonidine—glaucoma	0.000312	0.000551	CcSEcCtD
Vardenafil—Abdominal pain—Pilocarpine—glaucoma	0.000311	0.000549	CcSEcCtD
Vardenafil—Ill-defined disorder—Betaxolol—glaucoma	0.000311	0.000549	CcSEcCtD
Vardenafil—Diarrhoea—Acetazolamide—glaucoma	0.00031	0.000549	CcSEcCtD
Vardenafil—Rash—Bimatoprost—glaucoma	0.00031	0.000548	CcSEcCtD
Vardenafil—Dermatitis—Bimatoprost—glaucoma	0.00031	0.000548	CcSEcCtD
Vardenafil—Shock—Clonidine—glaucoma	0.000309	0.000546	CcSEcCtD
Vardenafil—Connective tissue disorder—Timolol—glaucoma	0.000309	0.000546	CcSEcCtD
Vardenafil—Pruritus—Brimonidine—glaucoma	0.000308	0.000545	CcSEcCtD
Vardenafil—Headache—Bimatoprost—glaucoma	0.000308	0.000545	CcSEcCtD
Vardenafil—Nervous system disorder—Clonidine—glaucoma	0.000308	0.000544	CcSEcCtD
Vardenafil—Hypersensitivity—Dorzolamide—glaucoma	0.000306	0.000542	CcSEcCtD
Vardenafil—Tachycardia—Clonidine—glaucoma	0.000306	0.000541	CcSEcCtD
Vardenafil—Hypersensitivity—Travoprost—glaucoma	0.000305	0.000539	CcSEcCtD
Vardenafil—Skin disorder—Clonidine—glaucoma	0.000305	0.000539	CcSEcCtD
Vardenafil—Hyperhidrosis—Clonidine—glaucoma	0.000303	0.000536	CcSEcCtD
Vardenafil—Visual impairment—Timolol—glaucoma	0.000303	0.000535	CcSEcCtD
Vardenafil—Malaise—Betaxolol—glaucoma	0.000302	0.000534	CcSEcCtD
Vardenafil—Nausea—Apraclonidine—glaucoma	0.000301	0.000533	CcSEcCtD
Vardenafil—Hypersensitivity—Brinzolamide—glaucoma	0.000301	0.000532	CcSEcCtD
Vardenafil—Vertigo—Betaxolol—glaucoma	0.000301	0.000532	CcSEcCtD
Vardenafil—Syncope—Betaxolol—glaucoma	0.0003	0.000531	CcSEcCtD
Vardenafil—Dizziness—Acetazolamide—glaucoma	0.0003	0.00053	CcSEcCtD
Vardenafil—Asthenia—Dorzolamide—glaucoma	0.000298	0.000527	CcSEcCtD
Vardenafil—Asthenia—Travoprost—glaucoma	0.000297	0.000525	CcSEcCtD
Vardenafil—Palpitations—Betaxolol—glaucoma	0.000296	0.000523	CcSEcCtD
Vardenafil—Pruritus—Dorzolamide—glaucoma	0.000294	0.00052	CcSEcCtD
Vardenafil—Loss of consciousness—Betaxolol—glaucoma	0.000294	0.00052	CcSEcCtD
Vardenafil—Eye disorder—Timolol—glaucoma	0.000294	0.000519	CcSEcCtD
Vardenafil—Asthenia—Brinzolamide—glaucoma	0.000293	0.000518	CcSEcCtD
Vardenafil—Hypotension—Clonidine—glaucoma	0.000293	0.000518	CcSEcCtD
Vardenafil—Pruritus—Travoprost—glaucoma	0.000293	0.000518	CcSEcCtD
Vardenafil—Tinnitus—Timolol—glaucoma	0.000293	0.000518	CcSEcCtD
Vardenafil—Nausea—Bimatoprost—glaucoma	0.000292	0.000516	CcSEcCtD
Vardenafil—Cardiac disorder—Timolol—glaucoma	0.000292	0.000515	CcSEcCtD
Vardenafil—Hypersensitivity—Pilocarpine—glaucoma	0.000289	0.000512	CcSEcCtD
Vardenafil—Pruritus—Brinzolamide—glaucoma	0.000289	0.000511	CcSEcCtD
Vardenafil—Vomiting—Acetazolamide—glaucoma	0.000288	0.00051	CcSEcCtD
Vardenafil—Dizziness—Brimonidine—glaucoma	0.000288	0.000509	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Clonidine—glaucoma	0.000286	0.000505	CcSEcCtD
Vardenafil—Angiopathy—Timolol—glaucoma	0.000285	0.000504	CcSEcCtD
Vardenafil—Chest pain—Betaxolol—glaucoma	0.000285	0.000504	CcSEcCtD
Vardenafil—Myalgia—Betaxolol—glaucoma	0.000285	0.000504	CcSEcCtD
Vardenafil—Arthralgia—Betaxolol—glaucoma	0.000285	0.000504	CcSEcCtD
Vardenafil—Diarrhoea—Dorzolamide—glaucoma	0.000285	0.000503	CcSEcCtD
Vardenafil—Headache—Acetazolamide—glaucoma	0.000284	0.000502	CcSEcCtD
Vardenafil—Anxiety—Betaxolol—glaucoma	0.000284	0.000502	CcSEcCtD
Vardenafil—Insomnia—Clonidine—glaucoma	0.000284	0.000502	CcSEcCtD
Vardenafil—Immune system disorder—Timolol—glaucoma	0.000284	0.000502	CcSEcCtD
Vardenafil—Diarrhoea—Travoprost—glaucoma	0.000283	0.000501	CcSEcCtD
Vardenafil—Mediastinal disorder—Timolol—glaucoma	0.000283	0.0005	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000283	0.0005	CcSEcCtD
Vardenafil—Asthenia—Pilocarpine—glaucoma	0.000282	0.000498	CcSEcCtD
Vardenafil—Paraesthesia—Clonidine—glaucoma	0.000282	0.000498	CcSEcCtD
Vardenafil—Discomfort—Betaxolol—glaucoma	0.000282	0.000498	CcSEcCtD
Vardenafil—Dyspnoea—Clonidine—glaucoma	0.00028	0.000494	CcSEcCtD
Vardenafil—Diarrhoea—Brinzolamide—glaucoma	0.00028	0.000494	CcSEcCtD
Vardenafil—Somnolence—Clonidine—glaucoma	0.000279	0.000493	CcSEcCtD
Vardenafil—Dry mouth—Betaxolol—glaucoma	0.000279	0.000493	CcSEcCtD
Vardenafil—Pruritus—Pilocarpine—glaucoma	0.000278	0.000491	CcSEcCtD
Vardenafil—Mental disorder—Timolol—glaucoma	0.000275	0.000486	CcSEcCtD
Vardenafil—Dizziness—Dorzolamide—glaucoma	0.000275	0.000486	CcSEcCtD
Vardenafil—Rash—Brimonidine—glaucoma	0.000275	0.000485	CcSEcCtD
Vardenafil—Dermatitis—Brimonidine—glaucoma	0.000274	0.000485	CcSEcCtD
Vardenafil—Dizziness—Travoprost—glaucoma	0.000274	0.000484	CcSEcCtD
Vardenafil—Erythema—Timolol—glaucoma	0.000273	0.000483	CcSEcCtD
Vardenafil—Headache—Brimonidine—glaucoma	0.000273	0.000482	CcSEcCtD
Vardenafil—Infection—Betaxolol—glaucoma	0.000271	0.00048	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Clonidine—glaucoma	0.000271	0.000479	CcSEcCtD
Vardenafil—Dizziness—Brinzolamide—glaucoma	0.00027	0.000478	CcSEcCtD
Vardenafil—Nausea—Acetazolamide—glaucoma	0.000269	0.000476	CcSEcCtD
Vardenafil—Diarrhoea—Pilocarpine—glaucoma	0.000269	0.000475	CcSEcCtD
Vardenafil—Shock—Betaxolol—glaucoma	0.000269	0.000475	CcSEcCtD
Vardenafil—Pain—Clonidine—glaucoma	0.000268	0.000474	CcSEcCtD
Vardenafil—Nervous system disorder—Betaxolol—glaucoma	0.000268	0.000474	CcSEcCtD
Vardenafil—Tachycardia—Betaxolol—glaucoma	0.000267	0.000471	CcSEcCtD
Vardenafil—Skin disorder—Betaxolol—glaucoma	0.000265	0.000469	CcSEcCtD
Vardenafil—Vomiting—Dorzolamide—glaucoma	0.000264	0.000467	CcSEcCtD
Vardenafil—Hyperhidrosis—Betaxolol—glaucoma	0.000264	0.000467	CcSEcCtD
Vardenafil—Rash—Dorzolamide—glaucoma	0.000262	0.000463	CcSEcCtD
Vardenafil—Dermatitis—Dorzolamide—glaucoma	0.000262	0.000463	CcSEcCtD
Vardenafil—Rash—Travoprost—glaucoma	0.000261	0.000461	CcSEcCtD
Vardenafil—Dermatitis—Travoprost—glaucoma	0.000261	0.000461	CcSEcCtD
Vardenafil—Headache—Dorzolamide—glaucoma	0.00026	0.00046	CcSEcCtD
Vardenafil—Vomiting—Brinzolamide—glaucoma	0.00026	0.000459	CcSEcCtD
Vardenafil—Dizziness—Pilocarpine—glaucoma	0.00026	0.000459	CcSEcCtD
Vardenafil—Headache—Travoprost—glaucoma	0.000259	0.000458	CcSEcCtD
Vardenafil—Nausea—Brimonidine—glaucoma	0.000259	0.000457	CcSEcCtD
Vardenafil—Feeling abnormal—Clonidine—glaucoma	0.000259	0.000457	CcSEcCtD
Vardenafil—Rash—Brinzolamide—glaucoma	0.000258	0.000456	CcSEcCtD
Vardenafil—Vision blurred—Timolol—glaucoma	0.000258	0.000456	CcSEcCtD
Vardenafil—Dermatitis—Brinzolamide—glaucoma	0.000258	0.000455	CcSEcCtD
Vardenafil—Gastrointestinal pain—Clonidine—glaucoma	0.000257	0.000454	CcSEcCtD
Vardenafil—Headache—Brinzolamide—glaucoma	0.000256	0.000453	CcSEcCtD
Vardenafil—Hypotension—Betaxolol—glaucoma	0.000255	0.000451	CcSEcCtD
Vardenafil—Angioedema—Timolol—glaucoma	0.00025	0.000442	CcSEcCtD
Vardenafil—Vomiting—Pilocarpine—glaucoma	0.00025	0.000442	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000249	0.00044	CcSEcCtD
Vardenafil—Abdominal pain—Clonidine—glaucoma	0.000248	0.000438	CcSEcCtD
Vardenafil—Rash—Pilocarpine—glaucoma	0.000248	0.000438	CcSEcCtD
Vardenafil—Dermatitis—Pilocarpine—glaucoma	0.000248	0.000438	CcSEcCtD
Vardenafil—Insomnia—Betaxolol—glaucoma	0.000247	0.000437	CcSEcCtD
Vardenafil—Nausea—Dorzolamide—glaucoma	0.000247	0.000437	CcSEcCtD
Vardenafil—Headache—Pilocarpine—glaucoma	0.000246	0.000435	CcSEcCtD
Vardenafil—Nausea—Travoprost—glaucoma	0.000246	0.000435	CcSEcCtD
Vardenafil—Vertigo—Timolol—glaucoma	0.000246	0.000434	CcSEcCtD
Vardenafil—Paraesthesia—Betaxolol—glaucoma	0.000245	0.000434	CcSEcCtD
Vardenafil—Syncope—Timolol—glaucoma	0.000245	0.000433	CcSEcCtD
Vardenafil—Dyspnoea—Betaxolol—glaucoma	0.000244	0.000431	CcSEcCtD
Vardenafil—Nausea—Brinzolamide—glaucoma	0.000243	0.000429	CcSEcCtD
Vardenafil—Palpitations—Timolol—glaucoma	0.000242	0.000427	CcSEcCtD
Vardenafil—Dyspepsia—Betaxolol—glaucoma	0.00024	0.000425	CcSEcCtD
Vardenafil—Loss of consciousness—Timolol—glaucoma	0.00024	0.000425	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Betaxolol—glaucoma	0.000236	0.000417	CcSEcCtD
Vardenafil—Pain—Betaxolol—glaucoma	0.000234	0.000413	CcSEcCtD
Vardenafil—Nausea—Pilocarpine—glaucoma	0.000233	0.000413	CcSEcCtD
Vardenafil—Myalgia—Timolol—glaucoma	0.000233	0.000412	CcSEcCtD
Vardenafil—Chest pain—Timolol—glaucoma	0.000233	0.000412	CcSEcCtD
Vardenafil—Arthralgia—Timolol—glaucoma	0.000233	0.000412	CcSEcCtD
Vardenafil—Anxiety—Timolol—glaucoma	0.000232	0.00041	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000231	0.000409	CcSEcCtD
Vardenafil—Hypersensitivity—Clonidine—glaucoma	0.000231	0.000409	CcSEcCtD
Vardenafil—Discomfort—Timolol—glaucoma	0.00023	0.000407	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—TXNIP—glaucoma	0.000228	0.00462	CbGpPWpGaD
Vardenafil—Dry mouth—Timolol—glaucoma	0.000228	0.000402	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—PTGFR—glaucoma	0.000226	0.00458	CbGpPWpGaD
Vardenafil—Asthenia—Clonidine—glaucoma	0.000225	0.000398	CcSEcCtD
Vardenafil—Feeling abnormal—Betaxolol—glaucoma	0.000225	0.000398	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—TBK1—glaucoma	0.000223	0.00453	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—OPN4—glaucoma	0.000223	0.00453	CbGpPWpGaD
Vardenafil—Anaphylactic shock—Timolol—glaucoma	0.000223	0.000394	CcSEcCtD
Vardenafil—Pruritus—Clonidine—glaucoma	0.000222	0.000392	CcSEcCtD
Vardenafil—Infection—Timolol—glaucoma	0.000222	0.000392	CcSEcCtD
Vardenafil—Shock—Timolol—glaucoma	0.00022	0.000388	CcSEcCtD
Vardenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00022	0.00446	CbGpPWpGaD
Vardenafil—Nervous system disorder—Timolol—glaucoma	0.000219	0.000387	CcSEcCtD
Vardenafil—PDE1B—Signaling by NGF—NTRK2—glaucoma	0.000219	0.00444	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—SOD1—glaucoma	0.000217	0.00441	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—SOD1—glaucoma	0.000217	0.00441	CbGpPWpGaD
Vardenafil—Skin disorder—Timolol—glaucoma	0.000217	0.000383	CcSEcCtD
Vardenafil—Hyperhidrosis—Timolol—glaucoma	0.000216	0.000381	CcSEcCtD
Vardenafil—Diarrhoea—Clonidine—glaucoma	0.000215	0.000379	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—HEYL—glaucoma	0.000213	0.00432	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—OPN4—glaucoma	0.000211	0.00428	CbGpPWpGaD
Vardenafil—Hypotension—Timolol—glaucoma	0.000209	0.000369	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—HEYL—glaucoma	0.000208	0.00421	CbGpPWpGaD
Vardenafil—Dizziness—Clonidine—glaucoma	0.000207	0.000367	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—PTGFR—glaucoma	0.000206	0.00419	CbGpPWpGaD
Vardenafil—Musculoskeletal discomfort—Timolol—glaucoma	0.000203	0.000359	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—C1QB—glaucoma	0.000202	0.0041	CbGpPWpGaD
Vardenafil—Insomnia—Timolol—glaucoma	0.000202	0.000357	CcSEcCtD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—BAD—glaucoma	0.000201	0.00409	CbGpPWpGaD
Vardenafil—Hypersensitivity—Betaxolol—glaucoma	0.000201	0.000356	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—PTGFR—glaucoma	0.000201	0.00408	CbGpPWpGaD
Vardenafil—Paraesthesia—Timolol—glaucoma	0.0002	0.000354	CcSEcCtD
Vardenafil—Vomiting—Clonidine—glaucoma	0.000199	0.000353	CcSEcCtD
Vardenafil—Dyspnoea—Timolol—glaucoma	0.000199	0.000352	CcSEcCtD
Vardenafil—Somnolence—Timolol—glaucoma	0.000198	0.000351	CcSEcCtD
Vardenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000198	0.00403	CbGpPWpGaD
Vardenafil—Rash—Clonidine—glaucoma	0.000198	0.00035	CcSEcCtD
Vardenafil—Dermatitis—Clonidine—glaucoma	0.000198	0.000349	CcSEcCtD
Vardenafil—Headache—Clonidine—glaucoma	0.000197	0.000347	CcSEcCtD
Vardenafil—Dyspepsia—Timolol—glaucoma	0.000196	0.000347	CcSEcCtD
Vardenafil—Asthenia—Betaxolol—glaucoma	0.000196	0.000346	CcSEcCtD
Vardenafil—Pruritus—Betaxolol—glaucoma	0.000193	0.000342	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Timolol—glaucoma	0.000193	0.000341	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—SMO—glaucoma	0.000193	0.00391	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—OPN4—glaucoma	0.000192	0.00389	CbGpPWpGaD
Vardenafil—Pain—Timolol—glaucoma	0.000191	0.000337	CcSEcCtD
Vardenafil—PDE1B—GPCR downstream signaling—PTGFR—glaucoma	0.00019	0.00385	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HDAC9—glaucoma	0.00019	0.00385	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—BAD—glaucoma	0.000189	0.00384	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.000188	0.00382	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—BAD—glaucoma	0.000188	0.00382	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—NGFR—glaucoma	0.000188	0.00381	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—BAD—glaucoma	0.000187	0.0038	CbGpPWpGaD
Vardenafil—Diarrhoea—Betaxolol—glaucoma	0.000187	0.00033	CcSEcCtD
Vardenafil—PDE1B—DAP12 signaling—BAD—glaucoma	0.000186	0.00379	CbGpPWpGaD
Vardenafil—Nausea—Clonidine—glaucoma	0.000186	0.000329	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—MMP1—glaucoma	0.000186	0.00377	CbGpPWpGaD
Vardenafil—Feeling abnormal—Timolol—glaucoma	0.000184	0.000325	CcSEcCtD
Vardenafil—Gastrointestinal pain—Timolol—glaucoma	0.000182	0.000323	CcSEcCtD
Vardenafil—Dizziness—Betaxolol—glaucoma	0.000181	0.000319	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—TXN—glaucoma	0.00018	0.00365	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—NTRK1—glaucoma	0.000178	0.00362	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—CAV1—glaucoma	0.000178	0.00362	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RPTOR—glaucoma	0.000176	0.00358	CbGpPWpGaD
Vardenafil—Abdominal pain—Timolol—glaucoma	0.000176	0.000312	CcSEcCtD
Vardenafil—PDE1B—DAP12 interactions—BAD—glaucoma	0.000175	0.00356	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—BAD—glaucoma	0.000175	0.00356	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—BAD—glaucoma	0.000174	0.00353	CbGpPWpGaD
Vardenafil—Vomiting—Betaxolol—glaucoma	0.000174	0.000307	CcSEcCtD
Vardenafil—PDE1B—Signaling by GPCR—PTGFR—glaucoma	0.000172	0.0035	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—BAD—glaucoma	0.000172	0.0035	CbGpPWpGaD
Vardenafil—Rash—Betaxolol—glaucoma	0.000172	0.000304	CcSEcCtD
Vardenafil—Dermatitis—Betaxolol—glaucoma	0.000172	0.000304	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—SMO—glaucoma	0.000172	0.00348	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—BAD—glaucoma	0.000172	0.00348	CbGpPWpGaD
Vardenafil—Headache—Betaxolol—glaucoma	0.000171	0.000303	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—NCK2—glaucoma	0.000171	0.00347	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—FN1—glaucoma	0.00017	0.00344	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—MMP1—glaucoma	0.000166	0.00336	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—MMP1—glaucoma	0.000166	0.00336	CbGpPWpGaD
Vardenafil—Hypersensitivity—Timolol—glaucoma	0.000164	0.000291	CcSEcCtD
Vardenafil—PDE1B—Signaling Pathways—LRP12—glaucoma	0.000163	0.00331	CbGpPWpGaD
Vardenafil—Nausea—Betaxolol—glaucoma	0.000162	0.000287	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—RPTOR—glaucoma	0.000161	0.00328	CbGpPWpGaD
Vardenafil—Asthenia—Timolol—glaucoma	0.00016	0.000283	CcSEcCtD
Vardenafil—PDE5A—Hemostasis—CAV1—glaucoma	0.000159	0.00322	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—CAV1—glaucoma	0.000159	0.00322	CbGpPWpGaD
Vardenafil—Pruritus—Timolol—glaucoma	0.000158	0.000279	CcSEcCtD
Vardenafil—PDE1B—Immune System—CTSA—glaucoma	0.000158	0.0032	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RPTOR—glaucoma	0.000157	0.00319	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NCK2—glaucoma	0.000156	0.00317	CbGpPWpGaD
Vardenafil—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000156	0.00316	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000155	0.00315	CbGpPWpGaD
Vardenafil—Diarrhoea—Timolol—glaucoma	0.000153	0.00027	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—NCK2—glaucoma	0.000152	0.00309	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—FN1—glaucoma	0.000151	0.00307	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—FN1—glaucoma	0.000151	0.00307	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HEYL—glaucoma	0.00015	0.00305	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGFR1OP—glaucoma	0.00015	0.00305	CbGpPWpGaD
Vardenafil—Dizziness—Timolol—glaucoma	0.000148	0.000261	CcSEcCtD
Vardenafil—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.000146	0.00297	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HDAC9—glaucoma	0.000145	0.00295	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB2—glaucoma	0.000145	0.00295	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—NGF—glaucoma	0.000145	0.00294	CbGpPWpGaD
Vardenafil—Vomiting—Timolol—glaucoma	0.000142	0.000251	CcSEcCtD
Vardenafil—Rash—Timolol—glaucoma	0.000141	0.000249	CcSEcCtD
Vardenafil—Dermatitis—Timolol—glaucoma	0.000141	0.000248	CcSEcCtD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.00014	0.00285	CbGpPWpGaD
Vardenafil—Headache—Timolol—glaucoma	0.00014	0.000247	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—EDN1—glaucoma	0.00014	0.00284	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—NOS3—glaucoma	0.000135	0.00274	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HDAC9—glaucoma	0.000133	0.0027	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TXNIP—glaucoma	0.000133	0.00269	CbGpPWpGaD
Vardenafil—Nausea—Timolol—glaucoma	0.000133	0.000234	CcSEcCtD
Vardenafil—PDE1B—Downstream signal transduction—CDKN1B—glaucoma	0.000132	0.00268	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—CDKN1B—glaucoma	0.000131	0.00266	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—CDKN1B—glaucoma	0.00013	0.00265	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TBK1—glaucoma	0.00013	0.00264	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—CDKN1B—glaucoma	0.00013	0.00264	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HDAC9—glaucoma	0.00013	0.00263	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EDN1—glaucoma	0.000127	0.00258	CbGpPWpGaD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000126	0.00256	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—EDN1—glaucoma	0.000125	0.00253	CbGpPWpGaD
Vardenafil—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000124	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000122	0.00248	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—CDKN1B—glaucoma	0.000122	0.00248	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—C3—glaucoma	0.000122	0.00248	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—CDKN1B—glaucoma	0.000121	0.00246	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—NOS3—glaucoma	0.00012	0.00244	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—NOS3—glaucoma	0.00012	0.00244	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.00012	0.00244	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—BAD—glaucoma	0.00012	0.00243	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—CDKN1B—glaucoma	0.000119	0.00243	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—C1QB—glaucoma	0.000118	0.00239	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000117	0.00237	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000115	0.00233	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SMO—glaucoma	0.000114	0.00231	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—OPN4—glaucoma	0.000113	0.0023	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EDN1—glaucoma	0.000113	0.0023	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—C3—glaucoma	0.000111	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SOD1—glaucoma	0.00011	0.00223	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—C3—glaucoma	0.000109	0.00221	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000108	0.0022	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HEYL—glaucoma	0.000105	0.00214	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TXN—glaucoma	0.000105	0.00213	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NTRK2—glaucoma	0.000104	0.00211	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SMO—glaucoma	0.000104	0.00211	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NARFL—glaucoma	0.000103	0.00208	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CA5A—glaucoma	0.000103	0.00208	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000102	0.00207	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN2B—glaucoma	0.000102	0.00207	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTGFR—glaucoma	0.000102	0.00207	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SMO—glaucoma	0.000101	0.00206	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—C3—glaucoma	9.88e-05	0.00201	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—VEGFA—glaucoma	9.71e-05	0.00197	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NTRK2—glaucoma	9.51e-05	0.00193	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HDAC9—glaucoma	9.37e-05	0.0019	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—GSTM1—glaucoma	9.32e-05	0.00189	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NTRK2—glaucoma	9.27e-05	0.00188	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	9.19e-05	0.00187	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NGFR—glaucoma	8.92e-05	0.00181	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—SMO—glaucoma	8.7e-05	0.00177	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—VEGFA—glaucoma	8.65e-05	0.00176	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—VEGFA—glaucoma	8.65e-05	0.00176	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MTHFR—glaucoma	8.55e-05	0.00174	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NTRK1—glaucoma	8.48e-05	0.00172	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MMP1—glaucoma	8.4e-05	0.0017	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—CDKN1B—glaucoma	8.32e-05	0.00169	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NGFR—glaucoma	8.16e-05	0.00166	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—CAV1—glaucoma	8.05e-05	0.00163	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RPTOR—glaucoma	7.97e-05	0.00162	CbGpPWpGaD
Vardenafil—PDE6G—Disease—APOE—glaucoma	7.96e-05	0.00162	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NGFR—glaucoma	7.95e-05	0.00161	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CAV1—glaucoma	7.89e-05	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—C3—glaucoma	7.86e-05	0.00159	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN2B—glaucoma	7.81e-05	0.00159	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NTRK1—glaucoma	7.75e-05	0.00157	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NCK2—glaucoma	7.72e-05	0.00157	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—FN1—glaucoma	7.66e-05	0.00156	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NTRK1—glaucoma	7.56e-05	0.00153	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2L1—glaucoma	7.52e-05	0.00153	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EDN1—glaucoma	7.5e-05	0.00152	CbGpPWpGaD
Vardenafil—PDE6G—Disease—BAD—glaucoma	7.42e-05	0.00151	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—glaucoma	7.34e-05	0.00149	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN2B—glaucoma	7.15e-05	0.00145	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN2B—glaucoma	6.96e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NGF—glaucoma	6.89e-05	0.0014	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EDN1—glaucoma	6.86e-05	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BAD—glaucoma	6.82e-05	0.00138	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.8e-05	0.00138	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EDN1—glaucoma	6.68e-05	0.00136	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HDAC9—glaucoma	6.56e-05	0.00133	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—C3—glaucoma	6.55e-05	0.00133	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—glaucoma	6.54e-05	0.00133	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—glaucoma	6.54e-05	0.00133	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—EDN1—glaucoma	6.31e-05	0.00128	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NGF—glaucoma	6.3e-05	0.00128	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NGF—glaucoma	6.14e-05	0.00125	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—APOE—glaucoma	6.1e-05	0.00124	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NOS3—glaucoma	6.09e-05	0.00124	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CAV1—glaucoma	6.04e-05	0.00123	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—C3—glaucoma	5.99e-05	0.00122	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOS3—glaucoma	5.97e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—C3—glaucoma	5.84e-05	0.00119	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FN1—glaucoma	5.75e-05	0.00117	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EDN1—glaucoma	5.73e-05	0.00116	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—BAD—glaucoma	5.68e-05	0.00115	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—APOE—glaucoma	5.58e-05	0.00113	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CAV1—glaucoma	5.53e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—C3—glaucoma	5.52e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTGS2—glaucoma	5.46e-05	0.00111	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—APOE—glaucoma	5.43e-05	0.0011	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.42e-05	0.0011	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CAV1—glaucoma	5.38e-05	0.00109	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.35e-05	0.00109	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FN1—glaucoma	5.26e-05	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1A—glaucoma	5.21e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—BAD—glaucoma	5.2e-05	0.00105	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN1B—glaucoma	5.17e-05	0.00105	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SMO—glaucoma	5.14e-05	0.00104	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FN1—glaucoma	5.13e-05	0.00104	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—BAD—glaucoma	5.06e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN2B—glaucoma	5.04e-05	0.00102	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CA1—glaucoma	5.01e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—C3—glaucoma	5.01e-05	0.00102	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CTSA—glaucoma	4.85e-05	0.000985	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA5A—glaucoma	4.77e-05	0.000968	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NARFL—glaucoma	4.77e-05	0.000968	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CDKN1B—glaucoma	4.75e-05	0.000964	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NTRK2—glaucoma	4.7e-05	0.000954	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CA2—glaucoma	4.58e-05	0.00093	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—C3—glaucoma	4.58e-05	0.000929	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOS3—glaucoma	4.57e-05	0.000927	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—glaucoma	4.39e-05	0.00089	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2L1—glaucoma	4.38e-05	0.000889	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.33e-05	0.00088	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.27e-05	0.000868	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—glaucoma	4.23e-05	0.000858	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOS3—glaucoma	4.18e-05	0.000848	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOS3—glaucoma	4.07e-05	0.000826	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGFR—glaucoma	4.03e-05	0.000818	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BAD—glaucoma	3.97e-05	0.000806	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1B—glaucoma	3.96e-05	0.000803	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOE—glaucoma	3.93e-05	0.000798	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CAV1—glaucoma	3.9e-05	0.000791	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NTRK1—glaucoma	3.83e-05	0.000777	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BAD—glaucoma	3.67e-05	0.000744	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—glaucoma	3.67e-05	0.000744	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1B—glaucoma	3.62e-05	0.000735	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN2B—glaucoma	3.53e-05	0.000716	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1B—glaucoma	3.53e-05	0.000716	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDN1—glaucoma	3.39e-05	0.000687	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—glaucoma	3.35e-05	0.00068	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—glaucoma	3.31e-05	0.000673	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—glaucoma	3.29e-05	0.000668	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—glaucoma	3.27e-05	0.000663	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TXN—glaucoma	3.23e-05	0.000655	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGF—glaucoma	3.11e-05	0.000632	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—glaucoma	3.01e-05	0.000611	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—C3—glaucoma	2.96e-05	0.000601	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—glaucoma	2.95e-05	0.000598	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—glaucoma	2.93e-05	0.000595	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1B—glaucoma	2.76e-05	0.000561	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—glaucoma	2.75e-05	0.000559	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CAV1—glaucoma	2.73e-05	0.000554	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—glaucoma	2.7e-05	0.000547	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FN1—glaucoma	2.6e-05	0.000527	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BAD—glaucoma	2.57e-05	0.000521	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1B—glaucoma	2.55e-05	0.000518	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTT1—glaucoma	2.5e-05	0.000508	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—glaucoma	2.49e-05	0.000505	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA1—glaucoma	2.33e-05	0.000473	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—glaucoma	2.27e-05	0.000462	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CTSA—glaucoma	2.26e-05	0.000458	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—glaucoma	2.22e-05	0.00045	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA2—glaucoma	2.13e-05	0.000432	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—glaucoma	2.06e-05	0.000419	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCA1—glaucoma	1.99e-05	0.000405	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1B1—glaucoma	1.99e-05	0.000405	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1B—glaucoma	1.79e-05	0.000363	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—glaucoma	1.66e-05	0.000336	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—glaucoma	1.59e-05	0.000324	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TXN—glaucoma	1.5e-05	0.000305	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—glaucoma	1.49e-05	0.000302	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—glaucoma	1.41e-05	0.000286	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—glaucoma	1.31e-05	0.000266	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAV1—glaucoma	1.3e-05	0.000264	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTT1—glaucoma	1.16e-05	0.000236	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—glaucoma	1.12e-05	0.000228	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—glaucoma	9.83e-06	0.000199	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1B1—glaucoma	9.27e-06	0.000188	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCA1—glaucoma	9.27e-06	0.000188	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—glaucoma	8.99e-06	0.000182	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—glaucoma	7.41e-06	0.00015	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—glaucoma	6.55e-06	0.000133	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—glaucoma	6.1e-06	0.000124	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAV1—glaucoma	6.04e-06	0.000123	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—glaucoma	4.57e-06	9.27e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—glaucoma	4.18e-06	8.48e-05	CbGpPWpGaD
